Clinical trials
Influenza, Human trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 4 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 4 |
| 2022 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Unknown status | 4 |
| Recruiting | 2 |
| Terminated | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 9 |
| BiondVax Pharmaceuticals ltd. | 5 |
| Hadassah Medical Organization | 4 |
| Tel-Aviv Sourasky Medical Center | 2 |
| Abt Associates | 1 |
| AstraZeneca | 1 |
| Barzilai Medical Center | 1 |
| BioCryst Pharmaceuticals | 1 |
| Centers for Disease Control and Prevention | 1 |
| Daniel Benjamin | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Influenza, Human | 32 |
| Respiratory Tract Infections | 4 |
| COVID-19 | 2 |
| Headache | 2 |
| Infections | 2 |
| Lung Diseases | 2 |
| Pneumonia | 2 |
| Respiratory Tract Diseases | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Adenoviridae Infections | 1 |
Trials
Showing 51 to 32 of 32. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.